Expanding upon what you said - When you get so many people with underlying diseases taking this drug you get data from subpopulations of people. We are going to find out that NASH people took this drug - Cancer patients - MS patients etc. They are going to see their blood work and say viola! This covid approval will be a treasure trove of data for quick clinical evidence of other indications. This is EXPLOSIVE! we just need to mark time and watch these stock price games play out.